You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 20, 2025

Details for Patent: 10,137,167


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,137,167
Title:Methods comprising desmopressin
Abstract: The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration, and maintaining or improving the reduction of nocturnal voids over the minimum treatment period.
Inventor(s): Klein; Bjarke Mirner (Frederiksberg, DK), Norgaard; Jens Peter (Frederiksberg, DK)
Assignee: Ferring B.V. (Hoofddorp, NL)
Application Number:14/143,866
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,137,167: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for both inventors and businesses, as it determines the extent of protection and the value of the intellectual property. This article will delve into the analysis of the scope and claims of United States Patent 10,137,167, using relevant frameworks and strategies to provide a detailed insight.

Understanding Patent Claims

Patent claims are the most critical part of a patent application, as they define the scope of the invention and what is protected by the patent. The USPTO allows up to 3 independent claims and a total of 20 claims in the initial application filing fee[2].

The Structure of Patent Claims

  • Independent Claims: These claims stand alone and do not depend on other claims. They are broad and define the main aspects of the invention.
  • Dependent Claims: These claims build upon independent claims and narrow down the scope to specific embodiments or variations of the invention.

Strategic Claim Management

Effective claim management is key to maximizing the value of a patent. This involves strategically adding and adjusting claims to ensure the patent utilizes its full entitlement of 20 claims. For every claim canceled, adding a new dependent claim can help maintain the full quota, enhancing the patent’s breadth and flexibility without additional costs[2].

Patent Scope Metrics

To measure the scope of a patent, metrics such as independent claim length and independent claim count can be used. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Subject Matter Eligibility Under 35 U.S.C. § 101

For a patent to be eligible, it must pass the subject matter eligibility test under 35 U.S.C. § 101. The USPTO uses a two-pronged framework introduced by the 2019 Revised Patent Subject Matter Eligibility Guidance (2019 PEG).

Prong One: Identifying Abstract Ideas

  • This step determines whether any claim element recites one of the enumerated groupings of abstract ideas: mathematical concepts, certain methods of organizing human activity, and mental processes. If a claim does not recite an abstract idea, it is patent-eligible[1].

Prong Two: Practical Application

  • If a claim recites an abstract idea, it must integrate the abstract idea into a practical application. This is demonstrated by showing that the additional elements (beyond those corresponding to the abstract idea) improve the functioning of a computer or another technology or technical field[1].

Practical Application Analysis for AI Inventions

For AI inventions, the 2024 Guidance Update emphasizes the importance of Prong Two. A strong argument under Prong Two involves demonstrating that the claims are directed to a specific, concrete technological advancement or solution to a technical problem. This requires a compelling narrative supported by the specification, highlighting the practical utility and real-world impact of the invention[1].

Evaluating Claim Improvements

To evaluate whether a claim includes an improvement to a computer or a technological field, one must examine the specification for technical explanations of the asserted improvement. The claim must accurately reflect this improvement, guiding the examiner through a clear and logical progression from the technical problem to the claimed innovation[1].

Patent Analytics and Claim Coverage

Patent analytics tools can help in understanding which patents and claims are actively protecting the intellectual property. A Claim Coverage Matrix categorizes patents by claims and scope concepts, providing a powerful tool for filtering, searching, and analyzing large numbers of patent claims. This helps in identifying gaps or opportunities in the patent landscape[5].

Case Study: United States Patent 10,137,167

To analyze the scope and claims of this patent, we need to:

Review the Claims

  • Examine the independent and dependent claims to understand the breadth and specificity of the invention.
  • Identify any abstract ideas and determine if they are integrated into a practical application as per Prong Two of the subject matter eligibility test.

Analyze the Specification

  • Look for technical explanations of the improvements asserted in the claims.
  • Ensure the claims accurately reflect these improvements and guide the examiner through a logical progression.

Use Patent Analytics Tools

  • Utilize tools like ClaimScape® to categorize the claims by scope concepts and identify any gaps or opportunities in the patent coverage.
  • Review interactive claim charts to determine if the scope concepts are applicable to target products or methods.

Key Takeaways

  • Strategic Claim Management: Ensure the patent utilizes its full entitlement of claims to maximize its breadth and flexibility.
  • Subject Matter Eligibility: Focus on demonstrating practical application under Prong Two, especially for AI inventions.
  • Patent Analytics: Use tools to categorize claims and identify gaps or opportunities in the patent landscape.
  • Specification Support: Ensure the claims are supported by clear technical explanations in the specification.
  • Claim Coverage: Regularly review and update claim charts to maintain comprehensive protection.

FAQs

Q: How many claims can be included in the initial patent application filing fee in the United States? A: The initial patent application filing fee covers the inclusion of up to 3 independent claims and a total of 20 claims[2].

Q: What is the significance of Prong Two in the subject matter eligibility test under 35 U.S.C. § 101? A: Prong Two requires demonstrating that the claims integrate an abstract idea into a practical application, which can be shown by improving the functioning of a computer or another technology or technical field[1].

Q: How can patent analytics tools help in managing patent claims? A: Patent analytics tools help in categorizing claims by scope concepts, identifying gaps or opportunities in the patent landscape, and generating interactive claim charts for easy review[5].

Q: Why is it important to ensure that the claims accurately reflect the improvements asserted in the specification? A: This ensures that the examiner can follow a clear and logical progression from the technical problem to the claimed innovation, supporting the argument for patent eligibility[1].

Q: What metrics can be used to measure the scope of a patent? A: Metrics such as independent claim length and independent claim count can be used to measure the scope of a patent and have explanatory power for several correlates of patent scope[3].

Sources

  1. The Importance of Prong Two of Step 2A for AI Inventions - Baker Botts
  2. Maximizing Patent Value: A Strategic Approach to Claim Management - Harrity LLP
  3. Patent Claims and Patent Scope - SSRN
  4. U.S. Patent and Trademark Office (USPTO) - USAGov
  5. Patent Analytics - Schwegman Lundberg & Woessner, P.A.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,137,167

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ferring Pharms Inc NOCDURNA desmopressin acetate TABLET;SUBLINGUAL 022517-002 Jun 21, 2018 DISCN Yes No 10,137,167 ⤷  Try for Free TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS, COMPRISING MONITORING A PATIENT'S SERUM SODIUM CONCENTRATION ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,137,167

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2712622 ⤷  Try for Free PA2017001 Lithuania ⤷  Try for Free
European Patent Office 2712622 ⤷  Try for Free 122017000006 Germany ⤷  Try for Free
European Patent Office 2712622 ⤷  Try for Free LUC00015 Luxembourg ⤷  Try for Free
European Patent Office 3225249 ⤷  Try for Free 300983 Netherlands ⤷  Try for Free
European Patent Office 3225249 ⤷  Try for Free CA 2019 00023 Denmark ⤷  Try for Free
European Patent Office 3225249 ⤷  Try for Free 2019C/520 Belgium ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.